PFIZER INC (PFE)
PFIZER INC (PFE) from its SEC filings: 2025 revenue $62.6 billion (-2% vs the year before), net margin 12%, free cash flow $9.1 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $62.6 billion |
| Revenue growth | -2% |
| Net income | $7.8 billion |
| Net margin | 12.4% |
| Free cash flow | $9.1 billion |
| Diluted EPS | $1.36 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +3% |
| Cash | $976.0 million |
| Long-term debt | $60.5 billion |
| Share count, 1 year | +0% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.